English

Nordic Nanovector ASA: Mandatory notification of trade - primary insider

Report this content

Malene Brondberg has today, 23 August 2019, purchased 1,722 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share.

Following this transaction, Malene Brondberg owns 7,277 shares in the Company and holds 40,000 PSUs.

This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act.

 

Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

Subscribe